Akebia Therapeutics
AKBA
#6962
Rank
S$0.54 B
Marketcap
$2.57
Share price
4.02%
Change (1 day)
112.58%
Change (1 year)

Akebia Therapeutics (AKBA) - Cash on Hand

Cash on Hand as of June 2024 : S$52.42 Million

According to Akebia Therapeutics's latest financial reports the company has S$52.42 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Akebia Therapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$56.69 M-53.26%
2022-12-31S$0.12 B-40.11%
2021-12-31S$0.20 B-43.03%
2020-12-31S$0.35 B78.52%
2019-12-31S$0.19 B-54.68%
2018-12-31S$0.43 B3.38%
2017-12-31S$0.42 B12.81%
2016-12-31S$0.37 B92.39%
2015-12-31S$0.19 B36.08%
2014-12-31S$0.14 B248.91%
2013-12-31S$41.24 M1955.38%
2012-12-31S$2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$11.95 B 22,713.24%๐Ÿ‡บ๐Ÿ‡ธ USA
S$18.60 B 35,394.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$26.93 B 51,286.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.35 B 586.69%๐Ÿ‡บ๐Ÿ‡ธ USA